| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |